The research actvities of IPPON are at the forefront of integrated personalized cancer medicine. For different cancers in urgent need for improved therapeutic outcomes, our joint mission is 1) to develop novel and more effective therapeutic strategies; 2) to improve the detection and understanding of mechanisms driving therapeutic resistance; 3) to identify and validate biomarkers for early detection and personalized therapy.